Pharmacological assessment of the duration of action of glycopyrrolate vs tiotropium and ipratropium in guinea-pig and human airways

作者: Gino Villetti , Marco Bergamaschi , Franco Bassani , Pier Tonino Bolzoni , Selena Harrison

DOI: 10.1038/SJ.BJP.0706724

关键词:

摘要: 1. Our study was aimed at investigating the duration of bronchodilator action antimuscarinc drug glycopyrrolate compared to tiotropium and ipratropium. In guinea-pig isolated trachea, time (t1/2) necessary for a contractile response carbachol (0.3 microM) return 50% recovery after washout antagonist studied. The offset effect glycopyrrolate, ipratropium (10 nM each) t1/2 = 4.0 +/- 0.5, > 4.5 0.5 0.1 h, respectively. At h from antagonist, 50 8, 10 4 70 7%, 2. human bronchus, effects (3 nM), (1 nM) 3.7 0.2; 6 3.0 0.2 6.0 101 10, 27 3 110 10%, 4. anaesthetized guinea-pigs, acetylcholine-induced bronchoconstriction markedly reduced by intratracheal instillation nmol kg(-1); 88.1 4% inhibition), (1.3 86.2 5% inhibition) or (1.45 10% inhibition). These inhibitory assessed 24 administration were 69.9 5 29.7 6%; 28.3 14.2 ipratropium, respectively, whereas they remained stable (83.5 4; 70.6 6) tiotropium. residual also 16 administration, proved be as low that found (31.2 vs 6%, respectively). 5. conclusion, glycopyrrolate-induced bronchodilation has longer than but less efficacy possible glycopyrrolate-based therapy asthma chronic obstructive pulmonary disease given once-a-day is not guaranteed present investigation.

参考文章(23)
Heribert Konzett, Richard Rössler, Versuchsanordnung zu Untersuchungen an der Bronchiàlmuskulatur Naunyn-schmiedebergs Archives of Pharmacology. ,vol. 195, pp. 71- 74 ,(1940) , 10.1007/BF01861842
Peter J. Barnes, The role of anticholinergics in chronic obstructive pulmonary disease. The American Journal of Medicine. ,vol. 117, pp. 24- 32 ,(2004) , 10.1016/J.AMJMED.2004.10.018
Nicholas J. Gross, Morton S. Skorodin, Role of the parasympathetic system in airway obstruction due to emphysema. The New England Journal of Medicine. ,vol. 311, pp. 421- 425 ,(1984) , 10.1056/NEJM198408163110701
El-Bdaoui Haddad, Hema Patel, Joelle E Keeling, Magdi H Yacoub, Peter J Barnes, Maria G Belvisi, Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways. British Journal of Pharmacology. ,vol. 127, pp. 413- 420 ,(1999) , 10.1038/SJ.BJP.0702573
Frederic B. Walker, Donald L. Kaiser, Mary Beth Kowal, Paul M. Suratt, Prolonged Effect of Inhaled Glycopyrrolate in Asthma Chest. ,vol. 91, pp. 49- 51 ,(1987) , 10.1378/CHEST.91.1.49
MICHAEL R. LITTNER, JONATHAN S. ILOWITE, DONALD P. TASHKIN, MITCHELL FRIEDMAN, CHARLES W. SERBY, SHAILENDRA S. MENJOGE, THEODORE J. WITEK, Long-Acting Bronchodilation with Once-Daily Dosing of Tiotropium (Spiriva) in Stable Chronic Obstructive Pulmonary Disease American Journal of Respiratory and Critical Care Medicine. ,vol. 161, pp. 1136- 1142 ,(2000) , 10.1164/AJRCCM.161.4.9903044
Ganesh Krishna, Viji Sankaranarayanan, Rajinder K Chitkara, New therapies for chronic obstructive pulmonary disease. Expert Opinion on Investigational Drugs. ,vol. 13, pp. 255- 267 ,(2004) , 10.1517/13543784.13.3.255
J. Cameron Muir, Charles F. von Gunten, Antisecretory agents in gastrointestinal obstruction. Clinics in Geriatric Medicine. ,vol. 16, pp. 327- 334 ,(2000) , 10.1016/S0749-0690(05)70059-8
Stephen I. Rennard, Charles W. Serby, Mo Ghafouri, Philip A. Johnson, Mitchell Friedman, Extended Therapy With Ipratropium Is Associated With Improved Lung Function in Patients With COPD: A Retrospective Analysis of Data From Seven Clinical Trials Chest. ,vol. 110, pp. 62- 70 ,(1996) , 10.1378/CHEST.110.1.62
E-B. Haddad, J. Rousell, Regulation of the expression and function of the M2 muscarinic receptor Trends in Pharmacological Sciences. ,vol. 19, pp. 322- 327 ,(1998) , 10.1016/S0165-6147(98)01231-0